Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nima Sharifi

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Endocrinology|September 5, 2013
Mechanisms of androgen receptor activation in castration-resistant prostate cancerNima Sharifi
Nature Reviews. Urology|April 1, 2015
Prostate cancer: CYP17A1 inhibitor failure-lessons for future drug developmentNima Sharifi
Mayo Clinic Proceedings|December 14, 2002
Gene function far from understoodNima Sharifi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2014
Steroid sidestep: evading androgen ablation by abirateroneNima Sharifi
Endocrinology|February 24, 2026
Androgen Metabolism in Prostate Cancer: Recent AdvancesNima Sharifi
The New England Journal of Medicine|June 3, 2026
Fasting, Glucocorticoids, and Breast CancerNima Sharifi
Endocrinology|June 28, 2021
Targeting Glucocorticoid Metabolism in Prostate CancerShelley Valle, Nima Sharifi
JAMA Network Open|March 20, 2024
Adrenal-Permissive HSD3B1 Genotype-An Invisible Stimulator of Prostate Cancer MortalityLina Schiffer, Nima Sharifi
Nature Reviews. Urology|December 13, 2017
HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancerDaniel Hettel, Nima Sharifi
Molecular Cancer Therapeutics|December 17, 2011
SOD mimetics: a novel class of androgen receptor inhibitors that suppresses castration-resistant growth of prostate cancerRusha Thomas, Nima Sharifi
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Endocrinology|September 5, 2013
Mechanisms of androgen receptor activation in castration-resistant prostate cancerNima Sharifi
Nature Reviews. Urology|April 1, 2015
Prostate cancer: CYP17A1 inhibitor failure-lessons for future drug developmentNima Sharifi
Mayo Clinic Proceedings|December 14, 2002
Gene function far from understoodNima Sharifi
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 2014
Steroid sidestep: evading androgen ablation by abirateroneNima Sharifi
Endocrinology|February 24, 2026
Androgen Metabolism in Prostate Cancer: Recent AdvancesNima Sharifi
The New England Journal of Medicine|June 3, 2026
Fasting, Glucocorticoids, and Breast CancerNima Sharifi
Endocrinology|June 28, 2021
Targeting Glucocorticoid Metabolism in Prostate CancerShelley Valle, Nima Sharifi
JAMA Network Open|March 20, 2024
Adrenal-Permissive HSD3B1 Genotype-An Invisible Stimulator of Prostate Cancer MortalityLina Schiffer, Nima Sharifi
Nature Reviews. Urology|December 13, 2017
HSD3B1 status as a biomarker of androgen deprivation resistance and implications for prostate cancerDaniel Hettel, Nima Sharifi
Molecular Cancer Therapeutics|December 17, 2011
SOD mimetics: a novel class of androgen receptor inhibitors that suppresses castration-resistant growth of prostate cancerRusha Thomas, Nima Sharifi
Pageof 17